109 related articles for article (PubMed ID: 18516018)
1. [The frequency and the course of the adverse effects of azathioprine/6-mercaptopurine treatment in patients with inflammatory bowel disease].
Cha JM; Kim HJ
Korean J Gastroenterol; 2008 May; 51(5):319-22. PubMed ID: 18516018
[No Abstract] [Full Text] [Related]
2. [The frequency and the course of the adverse effects of azathioprine/6-mercaptopurine treatment in patients with inflammatory bowel disease].
Kim JH; Cheon JH; Kim WH
Korean J Gastroenterol; 2008 May; 51(5):291-7. PubMed ID: 18516013
[TBL] [Abstract][Full Text] [Related]
3. Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine.
Su C; Lichtenstein GR
Gastroenterol Clin North Am; 2004 Jun; 33(2):209-34, viii. PubMed ID: 15177535
[TBL] [Abstract][Full Text] [Related]
4. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease.
Gearry RB; Barclay ML
J Gastroenterol Hepatol; 2005 Aug; 20(8):1149-57. PubMed ID: 16048561
[TBL] [Abstract][Full Text] [Related]
5. [Optimized thiopurine treatment in chronic inflammatory bowel disease].
Kiszka-Kanowitz M; Theede K; Nielsen AM
Ugeskr Laeger; 2015 Jun; 177(26):1253-5. PubMed ID: 26550625
[TBL] [Abstract][Full Text] [Related]
6. Azathioprine and mercaptopurine: lymphoma.
Prescrire Int; 2011 May; 20(116):126. PubMed ID: 21648178
[TBL] [Abstract][Full Text] [Related]
7. Hepatotoxicity associated with 6-methyl mercaptopurine formation during azathioprine and 6-mercaptopurine therapy does not occur on the short-term during 6-thioguanine therapy in IBD treatment.
van Asseldonk DP; Seinen ML; de Boer NK; van Bodegraven AA; Mulder CJ
J Crohns Colitis; 2012 Feb; 6(1):95-101. PubMed ID: 22261533
[TBL] [Abstract][Full Text] [Related]
8. A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate.
Sandborn WJ
Am J Gastroenterol; 1996 Mar; 91(3):423-33. PubMed ID: 8633486
[No Abstract] [Full Text] [Related]
9. [Therapy of chronic inflammatory bowel diseases with azathioprine, 6-mercaptopurine and 6-thioguanine. Clinico-pharmacologic aspects].
Schwab M; Herrlinger K; Schaeffeler E; Stange EF
Dtsch Med Wochenschr; 2003 Feb; 128(8):378-85. PubMed ID: 12594624
[No Abstract] [Full Text] [Related]
10. Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease?
Fangbin Z; Xiang G; Minhu C; Liang D; Feng X; Min H; Pinjin H
Ther Drug Monit; 2012 Dec; 34(6):695-701. PubMed ID: 23149442
[TBL] [Abstract][Full Text] [Related]
11. Mercaptopurine and inflammatory bowel disease: the other thiopurine.
Bermejo San José F; Algaba A; López Durán S; Guerra I; Aicart M; Hernández-Tejero M; Garrido E; de Lucas M; Bonillo D; López Sanromán A
Rev Esp Enferm Dig; 2017 Jan; 109(1):10-16. PubMed ID: 27809554
[TBL] [Abstract][Full Text] [Related]
12. Why measure thiopurine methyltransferase activity? Direct administration of 6-thioguanine might be the alternative for 6-mercaptopurine or azathioprine.
de Jong D; Mulder CJ; van Sorge AA
Gut; 2001 Dec; 49(6):874. PubMed ID: 11758505
[No Abstract] [Full Text] [Related]
13. Thiopurine therapy in inflammatory bowel disease.
Ha C; Dassopoulos T
Expert Rev Gastroenterol Hepatol; 2010 Oct; 4(5):575-88. PubMed ID: 20932143
[TBL] [Abstract][Full Text] [Related]
14. Observations on the use of allopurinol in combination with azathioprine or mercaptopurine.
Duley JA; Chocair PR; Florin TH
Aliment Pharmacol Ther; 2005 Dec; 22(11-12):1161-2. PubMed ID: 16305731
[No Abstract] [Full Text] [Related]
15. Clinical use and practical application of TPMT enzyme and 6-mercaptopurine metabolite monitoring in IBD.
Seidman EG
Rev Gastroenterol Disord; 2003; 3 Suppl 1():S30-8. PubMed ID: 12684587
[TBL] [Abstract][Full Text] [Related]
16. If at first you don't succeed...Try again?
Kane S
Am J Gastroenterol; 2001 Jul; 96(7):2260. PubMed ID: 11467666
[No Abstract] [Full Text] [Related]
17. Thiopurine methyltransferase activity combined with 6-thioguanine metabolite levels predicts clinical response to thiopurines in patients with inflammatory bowel disease.
Kwan LY; Devlin SM; Mirocha JM; Papadakis KA
Dig Liver Dis; 2008 Jun; 40(6):425-32. PubMed ID: 18304898
[TBL] [Abstract][Full Text] [Related]
18. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine.
Kandiel A; Fraser AG; Korelitz BI; Brensinger C; Lewis JD
Gut; 2005 Aug; 54(8):1121-5. PubMed ID: 16009685
[TBL] [Abstract][Full Text] [Related]
19. Thiopurines best practice.
Friedman A
J Gastroenterol Hepatol; 2016 Jun; 31 Suppl 1():6-7. PubMed ID: 26990458
[No Abstract] [Full Text] [Related]
20. Allopurinol-thiopurine combination therapy in inflammatory bowel disease: are there genetic clues to this puzzle?
Roberts RL; Gearry RB; Barclay ML
Pharmacogenomics; 2010 Nov; 11(11):1505-8. PubMed ID: 21121769
[No Abstract] [Full Text] [Related]
[Next] [New Search]
